Richard Newitter
Stock Analyst at Truist Financial
(4.36)
# 1,335
Out of 5,128 analysts
1052
Total ratings
47.9%
Success rate
6.7%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CARL Carlsmed | Reiterated: Buy | $23 | $17.30 | +32.95% | 10 | Nov 11, 2026 | |
| PODD Insulet | Reiterated: Hold | $153 → $160 | $149.29 | +7.17% | 17 | Nov 9, 2026 | |
| TFX Teleflex | Reiterated: Hold | $142 → $167 | $153.15 | +9.04% | 67 | Nov 9, 2026 | |
| GMED Globus Medical | Reiterated: Buy | $100 → $90 | $72.30 | +24.48% | 57 | Nov 6, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | $140 | $93.56 | +49.64% | 36 | Nov 6, 2026 | |
| PRCT PROCEPT BioRobotics | Reiterated: Hold | $21 → $24 | $23.51 | +2.08% | 43 | Nov 6, 2026 | |
| VCEL Vericel | Reiterated: Buy | $52 → $65 | $57.42 | +13.20% | 22 | Nov 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | $106 → $114 | $104.56 | +9.03% | 74 | Nov 5, 2026 | |
| EW Edwards Lifesciences | Upgraded: Buy | $95 → $113 | $105.80 | +6.81% | 42 | Nov 3, 2026 | |
| SYK Stryker | Reiterated: Hold | $310 → $305 | $312.39 | -2.37% | 51 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $215 → $255 | $246.03 | +3.65% | 25 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 | $44.20 | +15.38% | 55 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $62 → $78 | $60.54 | +28.84% | 68 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $25 | $24.14 | +3.56% | 18 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $23 → $28 | $16.51 | +69.59% | 16 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $17.88 | +62.24% | 1 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $28 | $17.51 | +59.91% | 10 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $102 | $81.39 | +25.32% | 13 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $86 → $99 | $100.99 | -1.97% | 49 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $5 | $5.34 | -6.37% | 37 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $110 → $127 | $126.42 | +0.46% | 19 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $103 | $101.25 | +1.23% | 60 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $580 → $510 | $439.89 | +15.94% | 73 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $32.58 | -38.61% | 17 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $54.51 | - | 1 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $370 → $374 | $320.77 | +16.59% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $14.35 | -9.41% | 33 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $127.17 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $28.30 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $240.37 | n/a | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $10.08 | n/a | 1 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $36.58 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $148 | $186.24 | n/a | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.965 | n/a | 10 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $5.38 | n/a | 3 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 59.09 → CHF 66.45 | CHF 60.28 | n/a | 11 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $173.01 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $55.40 | n/a | 13 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $260 → $250 | $215.71 | n/a | 16 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.70 | n/a | 3 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $770 | $166.97 | n/a | 26 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $141 | $50.48 | n/a | 14 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $45 | $107.25 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $55.98 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 | $25.74 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $140 | $283.52 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4.5 | $10.04 | n/a | 1 | Jul 15, 2016 |
Carlsmed
Nov 11, 2026
Reiterated: Buy
Price Target: $23
Current: $17.30
Upside: +32.95%
Insulet
Nov 9, 2026
Reiterated: Hold
Price Target: $153 → $160
Current: $149.29
Upside: +7.17%
Teleflex
Nov 9, 2026
Reiterated: Hold
Price Target: $142 → $167
Current: $153.15
Upside: +9.04%
Globus Medical
Nov 6, 2026
Reiterated: Buy
Price Target: $100 → $90
Current: $72.30
Upside: +24.48%
iRhythm Holdings
Nov 6, 2026
Reiterated: Buy
Price Target: $140
Current: $93.56
Upside: +49.64%
PROCEPT BioRobotics
Nov 6, 2026
Reiterated: Hold
Price Target: $21 → $24
Current: $23.51
Upside: +2.08%
Vericel
Nov 6, 2026
Reiterated: Buy
Price Target: $52 → $65
Current: $57.42
Upside: +13.20%
Zimmer Biomet Holdings
Nov 5, 2026
Reiterated: Hold
Price Target: $106 → $114
Current: $104.56
Upside: +9.03%
Edwards Lifesciences
Nov 3, 2026
Upgraded: Buy
Price Target: $95 → $113
Current: $105.80
Upside: +6.81%
Stryker
Nov 2, 2026
Reiterated: Hold
Price Target: $310 → $305
Current: $312.39
Upside: -2.37%
Oct 29, 2026
Reiterated: Buy
Price Target: $215 → $255
Current: $246.03
Upside: +3.65%
Oct 14, 2026
Reiterated: Buy
Price Target: $51
Current: $44.20
Upside: +15.38%
Oct 14, 2026
Reiterated: Hold
Price Target: $62 → $78
Current: $60.54
Upside: +28.84%
Oct 14, 2026
Reiterated: Buy
Price Target: $23 → $25
Current: $24.14
Upside: +3.56%
Sep 24, 2026
Rated: Buy
Price Target: $23 → $28
Current: $16.51
Upside: +69.59%
Sep 24, 2026
Initiated Coverage: Buy
Price Target: $29
Current: $17.88
Upside: +62.24%
Sep 24, 2026
Rated: Buy
Price Target: $31 → $28
Current: $17.51
Upside: +59.91%
Sep 23, 2026
Reiterated: Buy
Price Target: $102
Current: $81.39
Upside: +25.32%
Sep 2, 2026
Reiterated: Hold
Price Target: $86 → $99
Current: $100.99
Upside: -1.97%
Aug 10, 2026
Reiterated: Hold
Price Target: $4 → $5
Current: $5.34
Upside: -6.37%
Aug 4, 2026
Downgraded: Hold
Price Target: $110 → $127
Current: $126.42
Upside: +0.46%
Aug 4, 2026
Downgraded: Hold
Price Target: $125 → $103
Current: $101.25
Upside: +1.23%
Jul 17, 2026
Reiterated: Buy
Price Target: $580 → $510
Current: $439.89
Upside: +15.94%
Mar 2, 2026
Reiterated: Hold
Price Target: $20
Current: $32.58
Upside: -38.61%
Jan 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $54.51
Upside: -
Jan 16, 2026
Downgraded: Hold
Price Target: $370 → $374
Current: $320.77
Upside: +16.59%
Dec 23, 2025
Reiterated: Hold
Price Target: $13
Current: $14.35
Upside: -9.41%
Jun 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $127.17
Upside: n/a
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $28.30
Upside: n/a
Oct 16, 2024
Rated: Buy
Price Target: n/a
Current: $240.37
Upside: n/a
Jun 20, 2024
Rated: Buy
Price Target: n/a
Current: $10.08
Upside: n/a
Apr 17, 2024
Reiterated: Buy
Price Target: n/a
Current: $36.58
Upside: n/a
Aug 22, 2023
Reiterated: Hold
Price Target: $148
Current: $186.24
Upside: n/a
Oct 7, 2021
Reiterated: Buy
Price Target: n/a
Current: $0.965
Upside: n/a
Sep 10, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $5.38
Upside: n/a
Aug 17, 2021
Reiterated: Hold
Price Target: CHF 59.09 → CHF 66.45
Current: CHF 60.28
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: n/a
Current: $173.01
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $27
Current: $55.40
Upside: n/a
Aug 5, 2021
Rated: Hold
Price Target: $260 → $250
Current: $215.71
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $20
Current: $4.70
Upside: n/a
Jul 28, 2021
Rated: Buy
Price Target: $770
Current: $166.97
Upside: n/a
Jul 28, 2021
Rated: Hold
Price Target: $141
Current: $50.48
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $45
Current: $107.25
Upside: n/a
Jul 15, 2016
Reiterated: Buy
Price Target: $20
Current: $55.98
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $47
Current: $25.74
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $140
Current: $283.52
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $4.5
Current: $10.04
Upside: n/a